Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Tarrytown, New York, founded in 1988 by physician-scientist Leonard S. Schleifer and researcher George D. Yancopoulos. It develops and manufactures medicines derived from its own antibody-discovery technology, including the eye disease treatment Eylea and the immunology drug Dupixent, and grew into one of the leading biotechnology companies in the United States.
Facts
Company Type Founded Year HeadquartersTarrytown, New York, U.S. 1 Company Type
Company Type (category) Connections
Operates In
A major biotechnology company; classified in the atlas biotechnology-industry.
In the Other Atlases
Located In
Also in Geography Atlas: where this subject is located.
Sources
1. Wikipedia: Regeneron Pharmaceuticals
Lead paragraph
was founded in 1988
Infobox, Type field
Public
Infobox: hq_location
Tarrytown, New York, U.S.
View the Source2. StockAnalysis.com: StockAnalysis company profile for Regeneron Pharmaceuticals, Inc.
StockAnalysis.comCompany profile: EmployeesQuote, Company profile: Employees
Employees 15,410
3. U.S. Securities and Exchange Commission (EDGAR): SEC EDGAR submissions for REGENERON PHARMACEUTICALS, INC.
U.S. Securities and Exchange Commission (EDGAR)exchanges
"exchanges": [ "Nasdaq" ]
tickers
"tickers": [ "REGN" ]
View the Source Wikidata: Regeneron Pharmaceuticals, Inc.
Wikidata Q7308054, class allow-list match (w-wdresolver-0926)View the Source Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.